{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiapyqvuywm2tg55fp2ssrxgfhu4llp2l7grczrpcuamd4bttkqpim",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mp2xpiyp6qm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie6vydqrex2tpxdlvqfghmnqz7nm6yzih2czze67hq3ypyr6mdwzy"
    },
    "mimeType": "image/jpeg",
    "size": 307415
  },
  "path": "/news/2026-06-oral-glp-drug-weight-loss.html",
  "publishedAt": "2026-06-24T17:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine.",
  "title": "New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks"
}